GSK Pharma Announces 101st AGM on June 30, 2026

GlaxoSmithKline Pharmaceuticals Ltd has announced its 101st Annual General Meeting (AGM) to be held on Tuesday, June 30, 2026, at 11:00 a.m. via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The agenda includes the adoption of audited financial statements for the year ended March 31, 2026, declaration of a dividend of ₹57 per share, and the re-appointment of a director. Special business items include considering commission for Independent Directors for a five-year period and ratifying the remuneration for the cost auditor for the financial years ending March 31, 2026, and March 31, 2027. The meeting will be conducted in compliance with MCA circulars permitting virtual AGMs.